An artificial intelligence (AI)-enabled electrocardiograph (ECG) acquired during normal sinus rhythm can identify individuals with atrial fibrillation...
FDA research has laid the groundwork for replacing the thorough QT (TQT) study, a costly clinical trial required to determine whether new drugs cause abnormal heart rhythms (arrhythmias), with a more precise, less costly, and faster approach to testing.